Tag: COOL
-
![Core One Labs (COOL.C) Completes Acquisition of Akome Biotech]()
Core One Labs (COOL.C) Completes Acquisition of Akome Biotech
Core One Labs (COOL.C) has completed the acquisition of Akome Biotech, a psychedelic-based pharmaceuticals company focused on providing effective and safe solutions to patients suffering from stroke and neurological illnesses. “Closing on Akome is an important step for the Company, as we have added an outstanding asset and a strong team. The drug formulations being…
-
![Core One Labs (COOL.C) takes their artificial psilocybin research to UBC]()
Core One Labs (COOL.C) takes their artificial psilocybin research to UBC
Core One Labs (COOL.C) subsidiary, Vocan Biotechnologies, and the University of British Columbia (UBC), came to terms on a collaborative research agreement today, according to a press release. The collaboration gives Vocan access to a well-funded, world-class research facility and team to enhance their position in the nascent psychedelic medicine space, especially given the increasing…
-
![Core One Labs (COOL.C) begins work on proprietary DMT production]()
Core One Labs (COOL.C) begins work on proprietary DMT production
Core One Labs’ (COOL.C) wholly-owned subsidiary Vocan Biotechnologies has initiated the design and engineering of a proprietary enzymatic production system for API-grade N,N-dimethyltryptamine, commonly known as DMT. DMT, also known as the “spirit molecule”, is a naturally occurring psychedelic and is an active component in ayahuasca. It plays an important role in various rites of…
-
Does Core One Labs (COOL.C) have a solution for psilocybin’s dosing problem?
Core One’s objective in developing the psilocybin thinstrips is to assist with the delivery of revolutionary psychedelic treatment methods to address mental health conditions such as depression, anxiety and addictions.
-
Core One Labs (COOL.C) acquires 100% of a synthetic psilocybin company
“This transaction will significantly enhance Core One Labs’ ability to innovate our psychedelic drug development program,” stated Joel Shacker, CEO of Core Labs.
-
Core One Labs (COOL.C): Out of the ashes, a new business model and supportive shareholder base
In my experience with the North American public markets, few companies and executive teams got more lucky with their shareholder base than Lifestyle Delivery Systems. Their initial pitch was simple – they’d put extracted cannabis on thin film strips for easy and precise ingestion – and I, along with a ton of others, shoveled money…
-
![Core One Labs (COOL.C) unhalted today, and it will be a horror show: But that’s okay]()
Core One Labs (COOL.C) unhalted today, and it will be a horror show: But that’s okay
Halted since July of this year, right in the midst of a six week rise, the pubco formerly known as Lifestyle Delivery Systems, now Core One Labs (COOL.C), unhalted today and, as expected, took an immediate stock price dive. Having shut the door to trading in July at $0.73 as the exchange enforced a change…
